Volume 18, Number 6—June 2012
CME ACTIVITY - Research
Pretransplant Fecal Carriage of Extended-Spectrum β-Lactamase–producing Enterobacteriaceae and Infection after Liver Transplant, France
Frédéric Bert
, Béatrice Larroque, Catherine Paugam-Burtz, Federica Dondero, François Durand, Estelle Marcon, Jacques Belghiti, Richard Moreau, and Marie-Hélène Nicolas-Chanoine
, Béatrice Larroque, Catherine Paugam-Burtz, Federica Dondero, François Durand, Estelle Marcon, Jacques Belghiti, Richard Moreau, and Marie-Hélène Nicolas-Chanoine
Table 1
Characteristics of 710 liver transplant recipients included in study of ESBLE pretransplant fecal carriage and posttransplant infection, France, January 2001–April 2010*
| Characteristic | Value |
|---|---|
| Age, y, mean ± SD | 50 ± 11 |
| Male sex | 490 (69) |
| Viral hepatitis | 261 (36.7) |
| Hepatocellular carcinoma | 221 (31.1) |
| Alcoholism | 196 (27.6) |
| Acute liver failure | 74 (10.4) |
| Biliary disease | 61 (8.6) |
| HIV infection | 21 (3) |
| MELD score, mean ± SD | 18 ± 9 |
*Values are no. (%) patients except as indicated. ESBLE, extended spectrum β-lactamase–producing Enterobacteriaceae; MELD, Model for End-stage Liver Disease.
Page created: May 17, 2012
Page updated: May 17, 2012
Page reviewed: May 17, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.